Enlivex Therapeutics Ltd.

NASDAQ
ENLV
Stock
Yield per half year: -16.67%
Dividend yield: 0%
Sector: Healthcare

Share chart Enlivex Therapeutics Ltd.

Extended chart Simple chart
Financial Markets by TradingView

About Enlivex Therapeutics Ltd.

Enlivex Therapeutics Ltd. operates as a clinical-stage macrophage reprogramming immunotherapy company. It is developing Allocetra, a cell-based therapy to treat organ dysfunction and failure associated with sepsis that is in phase II clinical trial, as well as in preclinical trial to treat solid tumors. The company has a collaboration agreement with BeiGene to evaluate the safety and efficacy of Allocetra in combination with tislelizumab, an anti-PD-1 immune checkpoint inhibitor for the treatment of patients with advanced-stage solid tumors. Enlivex Therapeutics Ltd.

more details
is headquartered in Ness Ziona, Israel.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Main settings

IPO date 1995-12-12
ISIN IL0011319527
Industry Software
Sector Information Technology
Валюта usd
Валюта отчета usd
Сайт link
Цена ао 0.975
Change price per day: -4.52% (0.995)
Change price per week: -3.01% (0.9795)
Change price per month: -7.77% (1.03)
Change price per 3 month: -5% (1)
Change price per half year: -16.67% (1.14)
Change price per year: -31.16% (1.38)
Change price per 3 year: -77.7% (4.26)
Change price per 5 year: -81.61% (5.166)
Change price per 10 year: -86.03% (6.8)
Change price per year to date: -24% (1.25)
All parameters

Grade

Underestimation
Title Value Grade
P/S 0 0
P/BV 1.8 8
P/E 0 0
EV/EBITDA -2.26 0
Total: 3.5
Efficiency
Title Value Grade
ROA, % -78.92 0
ROE, % -96.62 0
Total: 0
Dividends
Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0
Debt
Title Value Grade
Debt/EBITDA -0.0428 10
Total: 10
Growth impulse
Title Value Grade
Yield Revenue, % -84.17 0
Yield Ebitda, % 281.34 10
Yield EPS, % 33.76 5
Total: 7
More

Main owners

Institutions Volume Share, %
Renaissance Technologies, LLC 62 089 0.33
Morgan Stanley 44 460 0.24
Susquehanna International Group, LLP 27 925 0.15
Edmond De Rothschild Holding S.A. 13 000 0.07
Geode Capital Management, LLC 10 420 0.06
Wells Fargo & Company 9 993 0.05
Citadel Advisors Llc 7 086 0.04
Citigroup Inc. 4 724 0.03
UBS Group AG 3 663 0.02
Steward Partners Investment Advisory, LLC 3 000 0.02

Similar companies

P/E & P/BVEV/Ebitda & Debt/Ebitda


Company management

Head Job title Payment Year of birth
Mr. Shai Novik M.B.A. Executive Chairman 528k 1966 (59 years)
Dr. Oren Hershkovitz Ph.D. Chief Executive Officer 273.6k 1977 (48 years)
Mr. Veronique Amor-Baroukh Senior Director of Operations N/A
Ms. Sigal Arad Director of HR N/A

About company

Address: Israel, Ness Ziona, 14 Einstein Street - Open in google maps, Open in yandex maps
Website: https://www.enlivex.com